Definition
Literature monitoring is the ongoing process of reviewing published medical, scientific, and clinical information for findings that may be relevant to a product’s safety profile, quality, regulatory status, or strategic positioning. It is a core element of pharmacovigilance and regulatory intelligence, particularly for products that are already on the market or moving through development.
Examples include review of journal articles, conference abstracts, case reports, and other publicly available information that may mention adverse events, product use, new treatment data, or emerging concerns. The purpose is to ensure that relevant information is not missed simply because it was published outside the organization’s own reporting channels.
Why It Matters
Literature monitoring helps organizations identify evidence that may affect product safety assessment, medical communication, or compliance planning. It provides an additional source of intelligence that complements spontaneous reports, clinical trial data, and internal safety review.
For teams operating in regulated environments, this process supports a more complete view of the external landscape. It can surface information that requires follow-up, escalation, or reassessment of current safety assumptions. In many organizations, it is a practical way to strengthen vigilance without relying solely on internal case intake mechanisms.
How It Relates to MedNova
MedNova supports organizations with a consultative approach to pharmacovigilance and regulatory readiness, including the structured oversight of safety-related information and the operational discipline required to manage it well. We help teams build processes that are efficient, compliant, and responsive to changing evidence.
Our support is particularly valuable where teams need to connect safety monitoring, medical information, and regulatory considerations in a way that remains practical and sustainable.
Frequently Asked Questions
What sources are included in literature monitoring?
It can include peer-reviewed journals, conference proceedings, case series, regulatory publications, and other public medical content. The scope depends on the product, therapeutic area, and the organization’s monitoring strategy.
Is literature monitoring only for pharmacovigilance?
While it is strongly associated with pharmacovigilance, literature monitoring also supports regulatory intelligence, medical affairs, and strategic portfolio oversight. It is useful wherever external evidence may affect product understanding or decision-making.
How does it support compliance?
By helping organizations capture and assess relevant published information in a timely and structured way, literature monitoring strengthens oversight and supports a more complete response framework for emerging safety concerns.